Randomized, Double-Blind Study Comparing Saruplase With Streptokinase Therapy in Acute Myocardial Infarction: The COMPASS Equivalence Trial fn1fn1This study was supported by Grünenthal GmbH, the manufacturer of saruplase.-Reference-Cited by-同舟云学术

Randomized, Double-Blind Study Comparing Saruplase With Streptokinase Therapy in Acute Myocardial Infarction: The COMPASS Equivalence Trial fn1fn1This study was supported by Grünenthal GmbH, the manufacturer of saruplase.

Published:1998-03 Issue:3 Volume:31 Page:487-493
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Tebbe Ulrich,Michels Rolf,Adgey Jennifer,Boland Jean,Caspi Avi,Charbonnier Bernard,Windeler Jürgen,Barth Hannes,Groves Robert,Hopkins Gwyn R.,Fennell William,Betriu Amadeo,Ruda Mikhail,Mlczoch Johannes

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference17 articles.

1. Indications for fibrinolytic therapy in suspected acute myocardial infarction;Lancet,1994

2. Recombinant human pro-urokinase (non-glycosylated);Flohé;Drugs Future,1986

3. Randomised double blind trial of recombinant prourokinase against streptokinase in acute myocardial infarction;Lancet,1989

4. Randomised, double-blind comparison of reteplase double-bolus administration with streptokinase in acute myocardial infarction (INJECT);Lancet,1995

5. Good Clinical Practice for Trials on Medicinal Products in the EC. Brussels: Commission of the European Community, 1990:III/3976/88-EN.

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of intracoronary pro-urokinase combined with low-pressure balloon pre-dilatation during percutaneous coronary intervention in patients with anterior ST-segment elevation myocardial infarction;Journal of Cardiothoracic Surgery;2024-04-05

2. Application and risk prediction of thrombolytic therapy in cardio-cerebrovascular diseases: a review;Thrombosis Journal;2023-09-04

3. Secondary electrocardiographic stratification of NSTEMI to identify an acutely occluded culprit artery;Physiological Measurement;2023-07-01

4. Effects of intracoronary low-dose prourokinase administration on ST-segment elevation in patients with myocardial infarction and a high thrombus burden: a randomized controlled trial;Journal of International Medical Research;2022-12

5. Effects of Intracoronary Pro-urokinase or Tirofiban on Coronary Flow During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction: A Multi-Center, Placebo-Controlled, Single-Blind, Randomized Clinical Trial;Frontiers in Cardiovascular Medicine;2021-08-02